Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses.
Shinde, Paurvi
Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses. [electronic resource] - Expert opinion on biological therapy 10 2018 - 1073-1083 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1744-7682
10.1080/14712598.2018.1518422 doi
Adjuvants, Immunologic--pharmacology
Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cancer Vaccines--pharmacology
Combined Modality Therapy
Drug Delivery Systems--methods
Humans
Immunity, Cellular--drug effects
Lymphocyte Activation--drug effects
Receptors, Tumor Necrosis Factor--antagonists & inhibitors
T-Lymphocytes--drug effects
Toll-Like Receptors--antagonists & inhibitors
Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses. [electronic resource] - Expert opinion on biological therapy 10 2018 - 1073-1083 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1744-7682
10.1080/14712598.2018.1518422 doi
Adjuvants, Immunologic--pharmacology
Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cancer Vaccines--pharmacology
Combined Modality Therapy
Drug Delivery Systems--methods
Humans
Immunity, Cellular--drug effects
Lymphocyte Activation--drug effects
Receptors, Tumor Necrosis Factor--antagonists & inhibitors
T-Lymphocytes--drug effects
Toll-Like Receptors--antagonists & inhibitors